InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | 2026-05-26 | Dizon Romeo R | Chief Financial Officer | Purchase | 5,004 | $1.00 | $5K | 126.0K | View ↗ | |
| 2026-03-06 | 2026-03-09 | Dizon Romeo R | Chief Financial Officer | Purchase | 1,110 | $1.26 | $1K | 121.0K | View ↗ | |
| 2026-02-17 | 2026-02-17 | Dizon Romeo R | Chief Financial Officer | Purchase | 2,200 | $1.34 | $3K | 119.9K | View ↗ |
| Metric | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Total revenues | $52.7M+8.2% | $48.7M-6.2% | $51.9M-9.0% | $57.0M+5.7% | $53.9M |
| Cost of revenues | $33.4M+14.7% | $29.2M-3.0% | $30.1M-4.9% | $31.6M+1.7% | $31.1M |
| Gross profit | $19.2M-1.4% | $19.5M-10.6% | $21.8M-14.0% | $25.4M+11.1% | $22.8M |
| Research and development | $3.7M-32.7% | $5.4M-20.2% | $6.8M-4.8% | $7.2M+4.5% | $6.9M |
| Sales and marketing | $10.4M-17.4% | $12.6M-22.5% | $16.2M-10.7% | $18.2M+24.2% | $14.6M |
| General and administrative | $7.7M-20.9% | $9.8M+11.8% | $8.7M+15.8% | $7.6M-14.7% | $8.9M |
| Total operating expenses | $21.8M-21.6% | $27.8M-12.6% | $31.8M-3.3% | $32.9M+8.4% | $30.4M |
| Loss from operations | -$2.6M+69.0% | -$8.3M+17.0% | -$10.0M-32.7% | -$7.5M-0.1% | -$7.5M |
| Other expense, net | -$1.8M-235.0% | -$540K-202.5% | $527K+778.3% | $60K-97.4% | $2.3M |
| Loss from operations before provision for income taxes | -$4.4M+50.5% | -$8.8M+6.7% | -$9.5M-26.7% | -$7.5M-44.3% | -$5.2M |
| Provision for income taxes | $57K-16.2% | $68K-24.4% | $90K+38.5% | $65K+62.5% | $40K |
| Net loss | -$4.4M+50.2% | -$8.9M+6.9% | -$9.6M-26.8% | -$7.5M-44.4% | -$5.2M |
| Basic | $16.9M+3.0% | $16.4M+1.9% | $16.1M+1.2% | $15.9M+3.4% | $15.4M |
| Diluted | $16.9M+3.0% | $16.4M+1.9% | $16.1M+1.2% | $15.9M+3.4% | $15.4M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth
IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...
IRIDEX Corporation Q1 2026 Earnings Call Summary
Iridex reaffirms $51M-$53M 2026 revenue outlook while targeting $600,000 annualized cost reduction